Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the comparative bioavailability between tamsulosin
hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.;
distributed by Teva Pharmaceuticals USA) and Flomax® (tamsulosin hydrochloride)0.4 mg
capsules (Manufactured by Yamanouchi Pharmaceutical Co., Japan; distributed by Boehringer
Ingelheim Pharmaceutical Inc. USA), after a single-dose in healthy subjects under fed
conditions.